Piramal Pharma Limited (BOM:543635)

Market Cap	201.66B -24.2%
Revenue (ttm)	88.71B -0.9%
Net Income	-1.64B
EPS	-1.24
Shares Out	n/a
PE Ratio	n/a
Forward PE	91.48
Dividend	0.14 (0.09%)
Ex-Dividend Date	Jul 16, 2025

Volume	45,669
Average Volume	195,308
Open	153.30
Previous Close	153.45
Day's Range	151.60 - 154.85
52-Week Range	142.95 - 241.00
Beta	n/a
RSI	35.45
Earnings Date	May 14, 2026

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 5,476
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543635

Financial Performance

In fiscal year 2025, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.